Latest Intravenous immunoglobulin Stories
Reportbuyer.com just published a new market research report:
Market Reports Online now offers Global IVIG Market Report: 2013 Edition research that provides an analysis of the world wide Intravenous immunoglobulin market with a special focus on the IVIG
Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings today from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease at the Alzheimer's Association International Conference (AAIC) in Boston, Mass.
“Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) potentially supplemented by approvals for Alzheimers disease”
- A serpent whose bite was fabled to produce intense thirst.